https://orcid.org/0000-0001-6660-020X
References
- de Pont AC. Attributable mortality of ventilator-associated pneumonia. Lancet Infect Dis. 2013;13(12):1014. doi:10.1016/S1473-3099(13)70300-1
- Branch-Elliman W, Wright SB, Howell MD. Determining the ideal strategy for ventilator-associated pneumonia prevention. Cost-benefit analysis. Am J Respir Crit Care Med. 2015;192(1):57–63. doi:10.1164/rccm.201412-2316OC
- Stone PW. Economic burden of healthcare-associated infections: an American perspective. Expert Rev Pharmacoecon Outcomes Res. 2009;9(5):417–422. doi:10.1586/erp.09.53
- Chawla R. Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control. 2008;36(4 Suppl):S93–100. doi:10.1016/j.ajic.2007.05.011
- Bergmans DC, Bonten MJ, Gaillard CA, et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother. 1997;39(4):527–535. doi:10.1093/jac/39.4.527
- Alp E, Cookson B, Erdem H, Rello J. Infection control bundles in intensive care: an international cross-sectional survey in low- and middle-income countries. J Hosp Infect. 2019;101(3):248–256. doi:10.1016/j.jhin.2018.07.022
- Cilloniz C, Martin-Loeches I, Garcia-Vidal C, San Jose A, Torres A. Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns. Int J Mol Sci. 2016;17(12):2120. doi:10.3390/ijms17122120
- Combes A, Figliolini C, Trouillet JL, et al. Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest. 2002;121(5):1618–1623. doi:10.1378/chest.121.5.1618
- Chaudhury A, Rani AS, Kalawat U, Sumant S, Verma A, Venkataramana B. Antibiotic resistance & pathogen profile in ventilator-associated pneumonia in a tertiary care hospital in India. Indian J Med Res. 2016;144(3):440–446. doi:10.4103/0971-5916.198679
- Zilberberg MD, Shorr AF. Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis. 2010;51(Suppl 1):S131–5. doi:10.1086/653062
- Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111. doi:10.1093/cid/ciw353
- Ferrer M, Difrancesco LF, Liapikou A, et al. Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome. Crit Care. 2015;19:450. doi:10.1186/s13054-015-1165-5
- Douglas IS. New diagnostic methods for pneumonia in the ICU. Curr Opin Infect Dis. 2016;29(2):197–204. doi:10.1097/QCO.0000000000000249
- Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162(2 Pt 1):505–511. doi:10.1164/ajrccm.162.2.9909095
- Center for Disease Control. Device associated module. Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) event. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/6pscvapcurrent.pdf. Accessed February 9, 2022.
- Ego A, Preiser JC, Vincent JL. Impact of diagnostic criteria on the incidence of ventilator-associated pneumonia. Chest. 2015;147(2):347–355. doi:10.1378/chest.14-0610
- Morris AC, Hay AW, Swann DG, et al. Reducing ventilator-associated pneumonia in intensive care: impact of implementing a care bundle. Crit Care Med. 2011;39(10):2218–2224. doi:10.1097/CCM.0b013e3182227d52
- Fengcai S, Di X, Qianpeng H, Hongke Z, Yiyu D. Microbial characteristics in culture-positive sepsis and risk factors of polymicrobial infection in ICU. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27(9):718–723.